Kangji Medical revenue up 8.9% despite hospital procurement delays

Kangji Medical Holdings (HKEX: 9997) announced an 8.9% increase in revenue to RMB1,008.6 million for the year ended December 31, 2024, compared to RMB926.0 million in 2023. Net profit attributable to owners of the parent rose 15.4% to RMB581.4 million, up from RMB504.0 million the previous year. The company attributed the revenue growth to increased sales of disposable products, offsetting procurement delays of medical equipment in hospitals. Export sales grew by 15.1% to RMB98.9 million, driven by the European market.